A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Cilofexor in Patients with Non-Cirrhotic Primary Sclerosing Cholangitis (PRIMIS)
JOURNAL OF HEPATOLOGY(2023)
Key words
Primary Sclerosing Cholangitis
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined